-
Mashup Score: 13A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy - 5 month(s) ago
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy
Source: consultqd.clevelandclinic.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 13A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy - 5 month(s) ago
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy
Source: consultqd.clevelandclinic.orgCategories: General Medicine News, Hem/OncsTweet-
A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy https://t.co/k8xUe7KUJF via @CleClinicMD @shilpaonc
-
-
Mashup Score: 13A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy - 5 month(s) ago
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy
Source: consultqd.clevelandclinic.orgCategories: General Medicine News, Hem/OncsTweet-
A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy https://t.co/k8xUe7KUJF via @CleClinicMD @shilpaonc
-
-
Mashup Score: 13A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy - 5 month(s) ago
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy
Source: consultqd.clevelandclinic.orgCategories: General Medicine News, Hem/OncsTweet-
A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy https://t.co/k8xUe7KUJF via @CleClinicMD @shilpaonc
-
-
Mashup Score: 13A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy - 5 month(s) ago
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy
Source: consultqd.clevelandclinic.orgCategories: General Medicine News, Hem/OncsTweet-
A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy https://t.co/k8xUe7KUJF via @CleClinicMD @shilpaonc
-
-
Mashup Score: 1Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis - PubMed - 6 month(s) ago
OHT represents a treatment option in patients with severe heart failure due to amyloidosis, allowing later intensive treatment with induction chemotherapy and ASCT. Although studies are lacking, immunosuppressive therapy after OHT might have some effect on clonal plasma cells.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hematologists1Tweet-
RT @amyloid_papers: Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis https://t.co/lDfMOhWmvB
-
-
Mashup Score: 11Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial - 8 month(s) ago
Nature Medicine – In the first-in-human trial of elranatamab, patients with refractory or relapsed multiple myeloma who received the bispecific antibody against BCMA and CD3 experienced no…
Source: www.nature.comCategories: Latest Headlines, Oncologists2Tweet-
RT @NBahlis: Out in today @NatureMedicine, https://t.co/TuvTDSldU6 FIH phase 1 trial with Elranatamab in R/R multiple myeloma defining the…
-
-
Mashup Score: 3
Original Article from The New England Journal of Medicine — Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
Source: www.nejm.orgCategories: Hematologists1, Latest HeadlinesTweet-
RT @MDonatoBMT: In patients w MM 1-3 lines of therapy, Cilta-cel better than SOC @ASTCT @theMMRF https://t.co/NrtaqENydn
-
-
Mashup Score: 1Daratumumab monotherapy for relapsed POEMS syndrome - 10 month(s) ago
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Our experience with Daratumumab in POEMS syndrome @AjHematology High response rates and durable remissions #mmsm @DimaDanai @JasonValent1 @CleClinicMD @RareDiseases https://t.co/KtzxdjIbeU
-
-
Mashup Score: 6Reducing Radiation-Related Toxicities with CPAP Machines - 10 month(s) ago
An innovative approach to protecting patients during breast and lung radiation therapy
Source: consultqd.clevelandclinic.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Reducing Radiation-Related Toxicities with CPAP Machines https://t.co/i9QfMDX3XH via @CleClinicMD @CShahMD
-
A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy https://t.co/k8xUe7KUJF via @CleClinicMD @shilpaonc